ID   LEG10_HUMAN             Reviewed;         142 AA.
AC   Q05315; C5HZ13; C5HZ14; Q0VDE3;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   10-MAY-2017, entry version 166.
DE   RecName: Full=Galectin-10;
DE            Short=Gal-10;
DE   AltName: Full=Charcot-Leyden crystal protein;
DE            Short=CLC;
DE   AltName: Full=Eosinophil lysophospholipase;
DE   AltName: Full=Lysolecithin acylhydrolase;
GN   Name=CLC; Synonyms=LGALS10, LGALS10A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 3-18 AND 93-110, AND
RP   VARIANT VAL-28.
RX   PubMed=8419478;
RA   Ackerman S.J., Corrette S.E., Rosenberg H.F., Bennett J.C.,
RA   Mastrianni D.M., Nicholson-Weller A., Weller P.F., Chin D.T.,
RA   Tenen D.G.;
RT   "Molecular cloning and characterization of human eosinophil Charcot-
RT   Leyden crystal protein (lysophospholipase). Similarities to IgE
RT   binding proteins and the S-type animal lectin superfamily.";
RL   J. Immunol. 150:456-468(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT VAL-28.
RX   PubMed=1577491; DOI=10.1016/0888-7543(92)90237-M;
RA   Mastrianni D.M., Eddy R.L., Rosenberg H.F., Corrette S.E., Shows T.B.,
RA   Tenen D.G., Ackerman S.J.;
RT   "Localization of the human eosinophil Charcot-Leyden crystal protein
RT   (lysophospholipase) gene (CLC) to chromosome 19 and the human
RT   ribonuclease 2 (eosinophil-derived neurotoxin) and ribonuclease 3
RT   (eosinophil cationic protein) genes (RNS2 and RNS3) to chromosome
RT   14.";
RL   Genomics 13:240-242(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT VAL-28.
RX   PubMed=9119387; DOI=10.1006/geno.1996.4590;
RA   Dyer K.D., Handen J.S., Rosenberg H.F.;
RT   "The genomic structure of the human Charcot-Leyden crystal protein
RT   gene is analogous to those of the galectin genes.";
RL   Genomics 40:217-221(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT VAL-28.
RC   TISSUE=Placenta;
RX   PubMed=19497882; DOI=10.1073/pnas.0903568106;
RA   Than N.G., Romero R., Goodman M., Weckle A., Xing J., Dong Z., Xu Y.,
RA   Tarquini F., Szilagyi A., Gal P., Hou Z., Tarca A.L., Kim C.J.,
RA   Kim J.S., Haidarian S., Uddin M., Bohn H., Benirschke K.,
RA   Santolaya-Forgas J., Grossman L.I., Erez O., Hassan S.S.,
RA   Zavodszky P., Papp Z., Wildman D.E.;
RT   "A primate subfamily of galectins expressed at the maternal-fetal
RT   interface that promote immune cell death.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:9731-9736(2009).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-28.
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-28.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-23; 92-99 AND 135-141, ACETYLATION AT SER-2,
RP   LACK OF GLYCOSYLATION AT ASN-136, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=16457599; DOI=10.1021/pr050341h;
RA   Ghafouri B., Irander K., Lindbom J., Tagesson C., Lindahl M.;
RT   "Comparative proteomics of nasal fluid in seasonal allergic
RT   rhinitis.";
RL   J. Proteome Res. 5:330-338(2006).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17502455; DOI=10.1182/blood-2007-01-069229;
RA   Kubach J., Lutter P., Bopp T., Stoll S., Becker C., Huter E.,
RA   Richter C., Weingarten P., Warger T., Knop J., Muellner S.,
RA   Wijdenes J., Schild H., Schmitt E., Jonuleit H.;
RT   "Human CD4+CD25+ regulatory T cells: proteome analysis identifies
RT   galectin-10 as a novel marker essential for their anergy and
RT   suppressive function.";
RL   Blood 110:1550-1558(2007).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=19758173; DOI=10.1111/j.1749-6632.2009.04627.x;
RA   De Re V., Simula M.P., Cannizzaro R., Pavan A., De Zorzi M.A.,
RA   Toffoli G., Canzonieri V.;
RT   "Galectin-10, eosinophils, and celiac disease.";
RL   Ann. N. Y. Acad. Sci. 1173:357-364(2009).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=22880030; DOI=10.1371/journal.pone.0042549;
RA   Chua J.C., Douglass J.A., Gillman A., O'Hehir R.E., Meeusen E.N.;
RT   "Galectin-10, a potential biomarker of eosinophilic airway
RT   inflammation.";
RL   PLoS ONE 7:E42549-E42549(2012).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=8747464; DOI=10.1016/S0969-2126(01)00275-1;
RA   Leonidas D.D., Elbert B.L., Zhou Z., Leffler H., Ackerman S.J.,
RA   Acharya K.R.;
RT   "Crystal structure of human Charcot-Leyden crystal protein, an
RT   eosinophil lysophospholipase, identifies it as a new member of the
RT   carbohydrate-binding family of galectins.";
RL   Structure 3:1379-1393(1995).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=10529229; DOI=10.1021/bi990756e;
RA   Swaminathan G.J., Leonidas D.D., Savage M.P., Ackerman S.J.,
RA   Acharya K.R.;
RT   "Selective recognition of mannose by the human eosinophil Charcot-
RT   Leyden crystal protein (galectin-10): a crystallographic study at 1.8
RT   A resolution.";
RL   Biochemistry 38:13837-13843(1999).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 2-139, ABSENCE OF
RP   LYSOPHOSPHOLIPASE ACTIVITY, AND INTERACTION WITH CEL.
RX   PubMed=11834744; DOI=10.1074/jbc.M200221200;
RA   Ackerman S.J., Liu L., Kwatia M.A., Savage M.P., Leonidas D.D.,
RA   Swaminathan G.J., Acharya K.R.;
RT   "Charcot-Leyden crystal protein (galectin-10) is not a dual function
RT   galectin with lysophospholipase activity but binds a lysophospholipase
RT   inhibitor in a novel structural fashion.";
RL   J. Biol. Chem. 277:14859-14868(2002).
CC   -!- FUNCTION: Regulates immune responses through the recognition of
CC       cell-surface glycans. Essential for the anergy and suppressive
CC       function of CD25-positive regulatory T-cells (Treg).
CC       {ECO:0000269|PubMed:17502455}.
CC   -!- SUBUNIT: Interacts with CEL. {ECO:0000269|PubMed:11834744}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-10485101, EBI-10485101;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:17502455}. Cytoplasmic granule
CC       {ECO:0000269|PubMed:17502455}. Note=Localized in granules from
CC       where it may be secreted or transported to other locations in the
CC       cell.
CC   -!- TISSUE SPECIFICITY: Expressed abundantly in the bone marrow.
CC       Expressed exclusively by eosinophils and basophils. Not detected
CC       in monocytes and neutrophils. Expressed in CD25-positive
CC       regulatory T-cells (Treg) (at protein level). Found in intestinal
CC       tissue from patients with Celiac disease, expression is directly
CC       related to the histological grade of mucosal damage and to the
CC       number of eosinophils found in the duodenal lesion (at protein
CC       level). Found in sputum of patients with eosinophilic inflammatory
CC       diseases such as asthma (at protein level).
CC       {ECO:0000269|PubMed:17502455, ECO:0000269|PubMed:19497882,
CC       ECO:0000269|PubMed:19758173, ECO:0000269|PubMed:22880030}.
CC   -!- MISCELLANEOUS: Forms hexagonal bipyramidal crystals, known as
CC       Charcot-Leyden crystals, in tissues and secretions from sites of
CC       eosinophil-associated inflammation and some myeloid leukemias.
CC   -!- CAUTION: Was originally thought to possess lysophospholipase
CC       activity but the absence of this activity has been shown by
CC       PubMed:11834744. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Galectin-10;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Stlect_277";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L01664; AAA36190.1; -; mRNA.
DR   EMBL; L01665; AAC37530.1; -; Genomic_DNA.
DR   EMBL; U68398; AAC51157.1; -; Genomic_DNA.
DR   EMBL; U68393; AAC51157.1; JOINED; Genomic_DNA.
DR   EMBL; U68395; AAC51157.1; JOINED; Genomic_DNA.
DR   EMBL; U68396; AAC51157.1; JOINED; Genomic_DNA.
DR   EMBL; FJ613334; ACR09636.1; -; mRNA.
DR   EMBL; FJ613335; ACR09637.1; -; mRNA.
DR   EMBL; AC005393; AAC28912.1; -; Genomic_DNA.
DR   EMBL; AC006133; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471126; EAW56914.1; -; Genomic_DNA.
DR   EMBL; BC119711; AAI19712.1; -; mRNA.
DR   EMBL; BC119712; AAI19713.1; -; mRNA.
DR   CCDS; CCDS33025.1; -.
DR   PIR; A46523; A46523.
DR   RefSeq; NP_001819.2; NM_001828.5.
DR   UniGene; Hs.889; -.
DR   PDB; 1G86; X-ray; 1.80 A; A=1-142.
DR   PDB; 1HDK; X-ray; 1.80 A; A=2-142.
DR   PDB; 1LCL; X-ray; 1.80 A; A=1-142.
DR   PDB; 1QKQ; X-ray; 1.80 A; A=1-142.
DR   PDBsum; 1G86; -.
DR   PDBsum; 1HDK; -.
DR   PDBsum; 1LCL; -.
DR   PDBsum; 1QKQ; -.
DR   ProteinModelPortal; Q05315; -.
DR   SMR; Q05315; -.
DR   BioGrid; 107592; 1.
DR   STRING; 9606.ENSP00000221804; -.
DR   DrugBank; DB02967; N-Ethylmaleimide.
DR   DrugBank; DB02983; Para-Mercury-Benzenesulfonic Acid.
DR   iPTMnet; Q05315; -.
DR   PhosphoSitePlus; Q05315; -.
DR   BioMuta; CLC; -.
DR   DMDM; 317373429; -.
DR   PaxDb; Q05315; -.
DR   PeptideAtlas; Q05315; -.
DR   PRIDE; Q05315; -.
DR   TopDownProteomics; Q05315; -.
DR   Ensembl; ENST00000221804; ENSP00000221804; ENSG00000105205.
DR   GeneID; 1178; -.
DR   KEGG; hsa:1178; -.
DR   UCSC; uc002omh.4; human.
DR   CTD; 1178; -.
DR   DisGeNET; 1178; -.
DR   GeneCards; CLC; -.
DR   H-InvDB; HIX0040154; -.
DR   HGNC; HGNC:2014; CLC.
DR   HPA; HPA041751; -.
DR   MalaCards; CLC; -.
DR   MIM; 153310; gene.
DR   neXtProt; NX_Q05315; -.
DR   OpenTargets; ENSG00000105205; -.
DR   PharmGKB; PA26541; -.
DR   eggNOG; KOG3587; Eukaryota.
DR   eggNOG; ENOG4111EA0; LUCA.
DR   GeneTree; ENSGT00530000064497; -.
DR   HOGENOM; HOG000015090; -.
DR   HOVERGEN; HBG006255; -.
DR   InParanoid; Q05315; -.
DR   KO; K13334; -.
DR   OMA; DKYQVMV; -.
DR   OrthoDB; EOG091G0QKJ; -.
DR   PhylomeDB; Q05315; -.
DR   TreeFam; TF315551; -.
DR   BRENDA; 3.1.1.5; 2681.
DR   EvolutionaryTrace; Q05315; -.
DR   GeneWiki; CLC_(gene); -.
DR   GenomeRNAi; 1178; -.
DR   PRO; PR:Q05315; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105205; -.
DR   CleanEx; HS_CLC; -.
DR   Genevisible; Q05315; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0097153; F:cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0046006; P:regulation of activated T cell proliferation; IMP:UniProtKB.
DR   GO; GO:0002667; P:regulation of T cell anergy; IMP:UniProtKB.
DR   GO; GO:0002724; P:regulation of T cell cytokine production; IMP:UniProtKB.
DR   GO; GO:0070231; P:T cell apoptotic process; IDA:UniProtKB.
DR   InterPro; IPR013320; ConA-like_dom.
DR   InterPro; IPR030648; Galectin_10.
DR   InterPro; IPR001079; Galectin_CRD.
DR   PANTHER; PTHR11346:SF124; PTHR11346:SF124; 1.
DR   Pfam; PF00337; Gal-bind_lectin; 1.
DR   SMART; SM00908; Gal-bind_lectin; 1.
DR   SMART; SM00276; GLECT; 1.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   PROSITE; PS51304; GALECTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Lectin; Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:16457599}.
FT   CHAIN         2    142       Galectin-10.
FT                                /FTId=PRO_0000076960.
FT   DOMAIN        6    138       Galectin. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00639}.
FT   SITE        136    136       Not glycosylated.
FT                                {ECO:0000269|PubMed:16457599}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000269|PubMed:16457599}.
FT   VARIANT      28     28       A -> V (in dbSNP:rs17608).
FT                                {ECO:0000269|PubMed:15057824,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:1577491,
FT                                ECO:0000269|PubMed:19497882,
FT                                ECO:0000269|PubMed:8419478,
FT                                ECO:0000269|PubMed:9119387}.
FT                                /FTId=VAR_014765.
FT   STRAND        6     11       {ECO:0000244|PDB:1G86}.
FT   STRAND       19     28       {ECO:0000244|PDB:1G86}.
FT   HELIX        30     32       {ECO:0000244|PDB:1G86}.
FT   STRAND       35     45       {ECO:0000244|PDB:1G86}.
FT   STRAND       50     57       {ECO:0000244|PDB:1G86}.
FT   TURN         58     60       {ECO:0000244|PDB:1G86}.
FT   STRAND       61     68       {ECO:0000244|PDB:1G86}.
FT   STRAND       76     78       {ECO:0000244|PDB:1G86}.
FT   STRAND       89     95       {ECO:0000244|PDB:1G86}.
FT   STRAND       97    104       {ECO:0000244|PDB:1G86}.
FT   STRAND      107    113       {ECO:0000244|PDB:1G86}.
FT   HELIX       118    120       {ECO:0000244|PDB:1G86}.
FT   STRAND      123    137       {ECO:0000244|PDB:1G86}.
SQ   SEQUENCE   142 AA;  16453 MW;  2744F0C082C6446E CRC64;
     MSLLPVPYTE AASLSTGSTV TIKGRPLACF LNEPYLQVDF HTEMKEESDI VFHFQVCFGR
     RVVMNSREYG AWKQQVESKN MPFQDGQEFE LSISVLPDKY QVMVNGQSSY TFDHRIKPEA
     VKMVQVWRDI SLTKFNVSYL KR
//
